Anne Tolstrup

CEO at AbtBioConsult ApS

Speaker

Anne B. Tolstrup, Ph.D., is an experienced biopharmaceutical industry professional with more than 25 years of involvement in the areas of biologics cell line and process development, genetics analyses, scale-up, process validation including process performance qualification (PPQ), clinical and commercial GMP manufacturing. She has extensive experience working in biotech and biopharma companies including Symphogen, Boehringer Ingelheim and Biogen as well as substantial experience with regulatory agencies, including FDA and EMA, regarding IND and BLA filings and audits. After starting her own consultancy business, AbtBioConsult in 2018 Anne has supported more than 35 clients in various aspects of biologics drug development including strategic support, CDMO collaborations, regulatory filings, and technical due diligence.